16.07.2025 22:17
Windtree Therapeutics, a publicly traded US biotech company, is making waves in the cryptocurrency world. A significant $60 million investment, spearheaded by Build and Build Corp, will fund a novel treasury strategy centered around Binance Coin (BNB). This groundbreaking move positions Windtree as a pioneer in the intersection of traditional finance and digital assets.
The investment agreement paves the way for Windtree to acquire both BNB and shares in the Osprey BNB Chain Trust. This initial tranche of $60 million is potentially expandable, with an additional $140 million available through further subscriptions, bringing the total potential investment to a substantial $200 million. The funds will be strategically allocated across custody and yield-generating activities, maximizing the return on their BNB holdings.
Subject to customary shareholder approval and other closing conditions, this transaction represents a landmark achievement. Upon successful completion, Windtree will hold the distinction of being the first NASDAQ-listed company to directly incorporate BNB into its balance sheet. This bold strategy aims to capitalize on the growing influence of Binance’s ecosystem within the broader cryptocurrency market.
Build and Build Corp, the lead investor, has explicitly voiced its strong confidence in Windtree’s crypto-focused venture. Patrick Horsman, a director at the firm, highlighted the deal's significance in addressing a critical market need: providing US investors with regulated access to BNB and the Binance ecosystem, an opportunity previously unavailable. The subsequent surge in BNB sentiment and trading activity underscores the market's enthusiastic response to this innovative investment strategy. Windtree's decision to embrace this new financial frontier promises to be a significant development for both the company and the broader digital asset landscape.
